Skip to main content
Donate

About FAST

News

April 17, 2024 Newsletter | What to Know

Read the full newsletter

click here

This week's e-newsletter includes:

  • An update from Ultragenyx Pharmaceuticals

  • Announcing FAST's new VP of Genetic Services & Education

  • A reminder to fill out the diagnostic module in the Global Angelman Syndrome Registry

  • Support for newly diagnosed families

  • An update on joint advocacy work with the Angelman Syndrome Foundation (ASF)

Join our newsletter to get these updates pushed straight to your inbox by clicking here.

Related

2024 Global Science Summit Recap
FAST Gains New Leaders on Board and Council
Introducing Dr. Edwin Weeber
FAST announces establishment of associated drug development accelerator AS²Bio

View All News

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.